Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2025)

Quantum Biopharma has disclosed Interest Coverage Ratio across 7 years of filings, most recently posting 15.02 for Q4 2025.

• Interest Coverage Ratio for Q4 2025 came in at 15.02, up 98.65% year-over-year; the trailing twelve-month figure through Mar 2026 was 40.57 (up 85.79% YoY), and the FY2025 annual result was 96.81, up 80.19% from the prior year.
• Interest Coverage Ratio came in at 15.02 for Q4 2025 at Quantum Biopharma, up from 51.09 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 507.25 in Q1 2021 to a low of 14760.08 in Q1 2023.
• The 5-year median for Interest Coverage Ratio is 157.87 (2024), against an average of 1227.6.
• Across the five-year window, Interest Coverage Ratio surged 655.18% in 2021 and tumbled 5224.53% in 2023, its largest moves.
• Quantum Biopharma's Interest Coverage Ratio stood at 670.79 in 2021, then surged by 142.94% to 288.03 in 2022, then increased by 19.77% to 344.97 in 2023, then slumped by 423.34% to 1115.43 in 2024, then jumped by 98.65% to 15.02 in 2025.
• The last three Interest Coverage Ratio figures came in at 15.02 (Q4 2025), 51.09 (Q3 2025), and 41.5 (Q2 2025), per Business Quant data.